Skip NavigationSkip to Content

Inhibition of Hiv-1 Replication By Combined Expression of Gag Dominant Negative Mutant and a Human Ribonuclease in a Tightly Controlled Hiv-1 Inducible Vector

  1. Author:
    Cara, A.
    Rybak, S. M.
    Newton, D. L.
    Crowley, R.
    Rottschafer, S. E.
    Reitz, M. S.
    Gusella, G. L.
    1. Year: 1998
  1. Journal: Gene Therapy
    1. 5
    2. 1
    3. Pages: 65-75
  2. Type of Article: Article
  1. Abstract:

    An HIV-1-based expression vector has been constructed that produces protective genes tightly regulated by HIV-1 Tat and Rev proteins. The vector contains either a single protective gene (HIV-1 gag dominant negative mutant (delta-gag)) or a combination of two different protective genes (delta-gag and eosinophil-derived neurotoxin (EDN), a human ribonuclease) which are expressed from a di-cistronic mRNA. After stable transfection of CEM T cells and following challenge with HIV-1, viral production was completely inhibited in cells transduced with the vector producing both delta-gag and EDN and delayed in cells producing delta-gag alone. In addition, cotransfection of HeLa-Tat cells with an infectious HIV-1 molecular clone and either protective vector demonstrated that the HIV-1 packaging signals present in the constructs were functional and allowed the efficient assembly of the protective RNAs into HIV-1 virions, thus potentially transmitting protection to the HIV-1 target cells. [References: 34]

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel